Literature DB >> 19357238

Ca2+-dependent permeability transition regulation in rat brain mitochondria by 2',3'-cyclic nucleotides and 2',3'-cyclic nucleotide 3'-phosphodiesterase.

Tamara Azarashvili1, Olga Krestinina, Anastasia Galvita, Dmitry Grachev, Yulia Baburina, Rolf Stricker, Yuri Evtodienko, Georg Reiser.   

Abstract

Recent evidence indicates that 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP), a marker enzyme of myelin and oligodendrocytes, is also present in neural and nonneural mitochondria. However, its role in mitochondria is still completely unclear. We found CNP in rat brain mitochondria and studied the effects of CNP substrates, 2',3'-cyclic nucleotides, on functional parameters of rat brain mitochondria. 2',3'-cAMP and 2',3'-cNADP stimulated Ca(2+) overload-induced Ca(2+) release from mitochondrial matrix. This Ca(2+) release under threshold Ca(2+) load correlated with membrane potential dissipation and mitochondrial swelling. The effects of 2',3'-cyclic nucleotides were suppressed by cyclosporin A, a potent inhibitor of permeability transition (PT). PT development is a key stage in initiation of apoptotic mitochondria-induced cell death. 2',3'-cAMP effects were observed on the functions of rat brain mitochondria only when PT was developed. This demonstrates involvement of 2',3'-cAMP in PT regulation in rat brain mitochondria. We also discovered that, under PT development, the specific enzymatic activity of CNP was reduced. Thus we hypothesize that suppression of CNP activity under threshold Ca(2+) load leads to elevation of 2',3'-cAMP levels that, in turn, promote PT development in rat brain mitochondria. Similar effects of 2',3'-cyclic nucleotides were observed in rat liver mitochondria. Involvement of CNP in PT regulation was confirmed in experiments using mitochondria from CNP-knockdown oligodendrocytes (OLN93 cells). CNP reduction in these mitochondria correlated with lowering the threshold for Ca(2+) overload-induced Ca(2+) release. Thus our results reveal a new function for CNP and 2',3'-cAMP in mitochondria, being a regulator/promotor of mitochondrial PT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357238     DOI: 10.1152/ajpcell.00006.2009

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  34 in total

1.  2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptors.

Authors:  Edwin K Jackson; Delbert G Gillespie; Raghvendra K Dubey
Journal:  J Pharmacol Exp Ther       Date:  2011-01-26       Impact factor: 4.030

Review 2.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

3.  Oxidative stress induces release of 2'-AMP from microglia.

Authors:  Travis C Jackson; Shawn E Kotermanski; Patrick M Kochanek; Edwin K Jackson
Journal:  Brain Res       Date:  2018-11-03       Impact factor: 3.252

4.  Extracellular cAMP-adenosine pathways in the mouse kidney.

Authors:  Edwin K Jackson; Jin Ren; Dongmei Cheng; Zaichuan Mi
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-08

5.  Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMP.

Authors:  Jonathan D Verrier; Patrick M Kochanek; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2015-05-21       Impact factor: 4.030

6.  The brain in vivo expresses the 2',3'-cAMP-adenosine pathway.

Authors:  Jonathan D Verrier; Travis C Jackson; Rashmi Bansal; Patrick M Kochanek; Ava M Puccio; David O Okonkwo; Edwin K Jackson
Journal:  J Neurochem       Date:  2012-03-20       Impact factor: 5.372

Review 7.  The myelin membrane-associated enzyme 2',3'-cyclic nucleotide 3'-phosphodiesterase: on a highway to structure and function.

Authors:  Arne Raasakka; Petri Kursula
Journal:  Neurosci Bull       Date:  2014-05-07       Impact factor: 5.203

8.  2',3'-Cyclic nucleotide 3'-phosphodiesterase as a messenger of protection of the mitochondrial function during melatonin treatment in aging.

Authors:  Yulia Baburina; Irina Odinokova; Tamara Azarashvili; Vladimir Akatov; John J Lemasters; Olga Krestinina
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-09       Impact factor: 3.747

9.  Role of 2',3'-cyclic nucleotide 3'-phosphodiesterase in the renal 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson; Delbert G Gillespie; Zaichuan Mi; Dongmei Cheng; Rashmi Bansal; Keri Janesko-Feldman; Patrick M Kochanek
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-07

10.  Renal 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Is an Important Determinant of AKI Severity after Ischemia-Reperfusion.

Authors:  Edwin K Jackson; Elizabeth V Menshikova; Zaichuan Mi; Jonathan D Verrier; Rashmi Bansal; Keri Janesko-Feldman; Travis C Jackson; Patrick M Kochanek
Journal:  J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.